blossompharm ltd
blossompharm ltd Company Information
Company Number
09921913
Next Accounts
Aug 2025
Industry
Other human health activities
Directors
Shareholders
anas abdinasir yusuf
Group Structure
View All
Contact
Registered Address
241 somerville road, birmingham, uk, B10 9DD
Website
-blossompharm ltd Estimated Valuation
Pomanda estimates the enterprise value of BLOSSOMPHARM LTD at £14k based on a Turnover of £31.9k and 0.44x industry multiple (adjusted for size and gross margin).
blossompharm ltd Estimated Valuation
Pomanda estimates the enterprise value of BLOSSOMPHARM LTD at £0 based on an EBITDA of £-18 and a 3.33x industry multiple (adjusted for size and gross margin).
blossompharm ltd Estimated Valuation
Pomanda estimates the enterprise value of BLOSSOMPHARM LTD at £406 based on Net Assets of £163 and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Blossompharm Ltd Overview
Blossompharm Ltd is a live company located in uk, B10 9DD with a Companies House number of 09921913. It operates in the other human health activities sector, SIC Code 86900. Founded in December 2015, it's largest shareholder is anas abdinasir yusuf with a 100% stake. Blossompharm Ltd is a established, micro sized company, Pomanda has estimated its turnover at £31.9k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Blossompharm Ltd Health Check
Pomanda's financial health check has awarded Blossompharm Ltd a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
8 Weak
Size
annual sales of £31.9k, make it smaller than the average company (£663.2k)
- Blossompharm Ltd
£663.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (6%)
- Blossompharm Ltd
6% - Industry AVG
Production
with a gross margin of 21.8%, this company has a higher cost of product (38.9%)
- Blossompharm Ltd
38.9% - Industry AVG
Profitability
an operating margin of -0.1% make it less profitable than the average company (5.5%)
- Blossompharm Ltd
5.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (17)
1 - Blossompharm Ltd
17 - Industry AVG
Pay Structure
on an average salary of £26k, the company has an equivalent pay structure (£26k)
- Blossompharm Ltd
£26k - Industry AVG
Efficiency
resulting in sales per employee of £31.9k, this is less efficient (£48.2k)
- Blossompharm Ltd
£48.2k - Industry AVG
Debtor Days
it gets paid by customers after 56 days, this is later than average (23 days)
- Blossompharm Ltd
23 days - Industry AVG
Creditor Days
its suppliers are paid after 70 days, this is slower than average (18 days)
- Blossompharm Ltd
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Blossompharm Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Blossompharm Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 96.7%, this is a higher level of debt than the average (26.2%)
96.7% - Blossompharm Ltd
26.2% - Industry AVG
BLOSSOMPHARM LTD financials
Blossompharm Ltd's latest turnover from November 2023 is estimated at £31.9 thousand and the company has net assets of £163. According to their latest financial statements, Blossompharm Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 4,967 | 5,298 | 953 | 4,843 | 4,820 | 3,940 | 4,096 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 4,000 | 0 | 0 | 0 | 13 | 2,265 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 4,967 | 5,298 | 4,953 | 4,843 | 4,820 | 3,940 | 4,109 | 2,265 |
| total assets | 4,967 | 5,298 | 4,953 | 4,843 | 4,820 | 3,940 | 4,109 | 2,265 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 4,804 | 5,117 | 630 | 4,467 | 4,480 | 2,973 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 4,122 | 0 | 0 | 0 | 3,255 | 1,993 |
| total current liabilities | 4,804 | 5,117 | 4,752 | 4,467 | 4,480 | 2,973 | 3,255 | 1,993 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 4,804 | 5,117 | 4,752 | 4,467 | 4,480 | 2,973 | 3,255 | 1,993 |
| net assets | 163 | 181 | 201 | 376 | 340 | 967 | 854 | 272 |
| total shareholders funds | 163 | 181 | 201 | 376 | 340 | 967 | 854 | 272 |
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -331 | 4,345 | -3,890 | 23 | 880 | -156 | 4,096 | 0 |
| Creditors | -313 | 4,487 | -3,837 | -13 | 1,507 | 2,973 | 0 | 0 |
| Accruals and Deferred Income | 0 | -4,122 | 4,122 | 0 | 0 | -3,255 | 1,262 | 1,993 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | 0 | -4,000 | 4,000 | 0 | 0 | -13 | -2,252 | 2,265 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | -4,000 | 4,000 | 0 | 0 | -13 | -2,252 | 2,265 |
blossompharm ltd Credit Report and Business Information
Blossompharm Ltd Competitor Analysis
Perform a competitor analysis for blossompharm ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in B10 area or any other competitors across 12 key performance metrics.
blossompharm ltd Ownership
BLOSSOMPHARM LTD group structure
Blossompharm Ltd has no subsidiary companies.
Ultimate parent company
BLOSSOMPHARM LTD
09921913
blossompharm ltd directors
Blossompharm Ltd currently has 1 director, Mr Anas Yusuf serving since Dec 2015.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Anas Yusuf | United Kingdom | 35 years | Dec 2015 | - | Director |
P&L
November 2023turnover
31.9k
+3%
operating profit
-18
0%
gross margin
21.8%
+0.41%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
163
-0.1%
total assets
5k
-0.06%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
blossompharm ltd company details
company number
09921913
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
December 2015
age
10
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
November 2023
previous names
N/A
accountant
-
auditor
-
address
241 somerville road, birmingham, uk, B10 9DD
Bank
-
Legal Advisor
-
blossompharm ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to blossompharm ltd.
blossompharm ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BLOSSOMPHARM LTD. This can take several minutes, an email will notify you when this has completed.
blossompharm ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
